CORCYM Revenue and Competitors
Estimated Revenue & Valuation
- CORCYM's estimated annual revenue is currently $92.4M per year.
- CORCYM's estimated revenue per employee is $251,000
Employee Data
- CORCYM has 368 Employees.
- CORCYM grew their employee count by 8% last year.
CORCYM's People
Name | Title | Email/Phone |
---|---|---|
1 | CIO | Reveal Email/Phone |
2 | Sr VP Sales and Marketing, North America | Reveal Email/Phone |
3 | VP Commercial Japan / ANZ | Reveal Email/Phone |
4 | Head Statistics, Data Management and Clinical Operations | Reveal Email/Phone |
5 | Head Legal Affairs - General Counsel | Reveal Email/Phone |
6 | Head Medical Affairs | Reveal Email/Phone |
7 | Head Reporting, Acc. Consolidation | Reveal Email/Phone |
8 | Head Clinical, Quality and Regulatory Affairs | Reveal Email/Phone |
9 | Head Market Access Europe | Reveal Email/Phone |
10 | VP and Global Head Market Access, Government Affairs and HEOR | Reveal Email/Phone |
CORCYM Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $86.6M | 345 | 2% | N/A | N/A |
#2 | $369.5M | 920 | -23% | $974.7M | N/A |
#3 | $1M | 4 | 0% | N/A | N/A |
#4 | $258.8M | 1031 | 18% | N/A | N/A |
#5 | $136M | 542 | 8% | N/A | N/A |
#6 | $19.8M | 79 | -2% | N/A | N/A |
#7 | $51.7M | 206 | 7% | N/A | N/A |
#8 | $40.9M | 163 | 10% | N/A | N/A |
#9 | $85.1M | 339 | 9% | N/A | N/A |
#10 | $40.4M | 161 | 8% | N/A | N/A |
What Is CORCYM?
We are committed to be a leading company dedicated to Heart Surgeons and their patients by providing the best solutions to fight structural heart disease.
keywords:N/AN/A
Total Funding
368
Number of Employees
$92.4M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $60.8M | 368 | 46% | $289M |
#2 | $82.8M | 368 | 9% | N/A |
#3 | $124.2M | 368 | 10% | N/A |
#4 | $104.4M | 368 | 7% | N/A |
#5 | $15M | 369 | 14% | N/A |